rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Howard Clowes

Director

Company insider

Files Form 4 as: Director, Cerenome.

In numbers

Trades disclosed
25
Buys
7
Sells
0
Bought
$66K
Sold
$0
Companies
1
Companies where not an officer
1
First trade
25 Jun 2020
Last trade
1 Oct 2026
Last filed
1 Oct 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
CNSY CerenomeDirector · Medical Devices · last 1 Oct 20267 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
1 Oct 2026filed 1 Oct 2026CNSY CerenomeMedical DevicesSEC FORM 4 Code M—921 at $0.00filing
1 Oct 2026filed 1 Oct 2026CNSY Cerenomeoption or derivative · Medical DevicesSEC FORM 4 Code M—921 at $0.00filing
1 Jul 2026filed 1 Jul 2026Plus TherapeuticsMedical DevicesSEC FORM 4 Code M—922 at $0.00filing
1 Jul 2026filed 1 Jul 2026Plus Therapeuticsoption or derivative · Medical DevicesSEC FORM 4 Code M—922 at $0.00filing
1 Jul 2026filed 1 Jul 2026Plus Therapeuticsoption or derivative · Medical DevicesSEC FORM 4 Code M—922 at $0.00filing
1 Jul 2026filed 1 Jul 2026Plus TherapeuticsMedical DevicesSEC FORM 4 Code M—922 at $0.00filing
14 May 2026filed 18 May 2026Plus Therapeuticsoption or derivative · Medical DevicesSEC FORM 4 Code A—3,686 at $0.00filing
14 May 2026filed 18 May 2026Plus Therapeuticsoption or derivative · Medical DevicesSEC FORM 4 Code A—3,686 at $0.00filing
14 May 2026filed 18 May 2026Plus Therapeuticsoption or derivative · Medical DevicesSEC FORM 4 Code A—3,686 at $0.00filing
14 May 2026filed 18 May 2026Plus Therapeuticsoption or derivative · Medical DevicesSEC FORM 4 Code A—3,686 at $0.00filing
13 Aug 2025filed 15 Aug 2025Plus Therapeuticsoption or derivative · Medical DevicesSEC FORM 4 Code A—297,794 at $0.00filing
18 Feb 2025filed 20 Feb 2025Plus Therapeuticsoption or derivative · Medical DevicesSEC FORM 4 Code A—40,122 at $0.00filing
11 Sep 2024filed 13 Sep 2024Plus TherapeuticsMedical DevicesSEC FORM 4 Bought$6,7005,000 at $1.34filing
11 Sep 2024filed 12 Sep 2024Plus Therapeuticsoption or derivative · Medical DevicesSEC FORM 4 Code A—3,650 at $0.00filing
8 May 2024filed 10 May 2024Plus Therapeuticsoption or derivative · Medical DevicesSEC FORM 4 Code A—19,608 at $0.00filing
8 May 2024filed 10 May 2024Plus TherapeuticsMedical DevicesSEC FORM 4 Bought$20K9,804 at $2.04filing
22 Feb 2024filed 26 Feb 2024Plus Therapeuticsoption or derivative · Medical DevicesSEC FORM 4 Code A—2,250 at $0.00filing
13 Sep 2023filed 15 Sep 2023Plus TherapeuticsMedical DevicesSEC FORM 4 Bought$10,0006,993 at $1.43filing
6 Jun 2023filed 8 Jun 2023Plus TherapeuticsMedical DevicesSEC FORM 4 Bought$3,9801,000 at $3.98filing
3 May 2023filed 4 May 2023Plus TherapeuticsMedical DevicesSEC FORM 4 Bought$9,1002,500 at $3.64filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Health Care7

Buys in green, sells in red, by the company’s sector.

Related people

Marc H. HedrickChief Executive Officer · Chief Executive Officer at Plus Therapeutics, filing Form 4 there in the last year
Ronald Asbury AndrewsDirector · Director at Plus Therapeutics, filing Form 4 there in the last year
Richard J. HawkinsDirector · Director at Plus Therapeutics, filing Form 4 there in the last year
Kyle GuseDirector · Director at Plus Therapeutics, filing Form 4 there in the last year
An van Es-JohanssonDirector · Director at Plus Therapeutics, filing Form 4 there in the last year